Revised Ezetimibe & Ezetimibe-Statin Restrictions effective 1 October 2018
Page last updated: 28 September 2018
As a result of the Post-market Review of Ezetimibe, revised PBS restrictions for ezetimibe and ezetimibe-statin products will be effective 1 October 2018. While the restrictions will remain Authority (Streamlined) with the same PBS item codes, the current streamlined codes will change. This will only effect PBS prescriptions written on or after 1 October 2018. Prescriptions written prior to 1 October 2018 will be valid for the lifetime of the prescription. For further details, refer to the Schedule of Pharmaceutical Benefits (Summary of Changes) available on the PBS Publications page from 1 October. For more information on the Review, please visit the Post-market Review of Ezetimibe web page.